On-demand proton pump inhibitor therapy in patients with gastro-oesophageal reflux disease

Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease

2005 • 1,119 citations

An evidence-based appraisal of reflux disease management --- the Genval Workshop Report

1999 • 907 citations

Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction

1993 • 886 citations

Updated Guidelines for The Diagnosis and Treatment of Gastroesophageal Reflux Disease

1999 • 544 citations

The Impact of Gastroesophageal Reflux Disease on Health-related Quality of Life 11Supported by research funding from Astra/Merck, Wayne, Pennsylvania.

1998 • 436 citations

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

2001 • 383 citations

Opposing time trends of peptic ulcer and reflux disease

1998 • 381 citations

On demand therapy with omeprazole for the long‐term management of patients with heartburn without oesophagitis—a placebo‐controlled randomized trial

1999 • 203 citations

Esomeprazole 20 mg maintains symptom control in endoscopy‐negative gastro‐oesophageal reflux disease: a controlled trial of ‘on‐demand’ therapy for 6 months

2001 • 187 citations

Pharmacokinetics and pharmacodynamics of esomeprazole, the S‐isomer of omeprazole

2001 • 175 citations

Three year follow up of patients with gastrooesophageal reflux disease.

1992 • 163 citations

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine

1999 • 139 citations

Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.

1998 • 118 citations

A Cost-Effectiveness Analysis of Prescribing Strategies in The Management of Gastroesophageal Reflux Disease

2000 • 116 citations

Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a Health Maintenance Organization

2000 • 113 citations

Review article: drug interactions with agents used to treat acid‐related diseases

1999 • 112 citations

Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease.

2002 • 94 citations

Gut in 1999

1999 • 76 citations

Esomeprazole (E) 40 mg provides more effective acid control than pantoprazole (P) 40 mg

2000 • 48 citations

New-generation proton pump inhibitors: overcoming the limitations of early-generation agents.

2001 • 43 citations

Does Helicobacter pylori affect gastric mucin expression? Relationship between gastric antral mucin expression and H. pylori colonization

2001 • 41 citations

On‐demand treatment of gastro‐oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placebo

1998 • 38 citations

On-demand therapy for gastro-oesophageal reflux disease.

2001 • 32 citations

Meta-Analysis of the Effect of Placebo on the Outcome of Medically Treated Reflux Esophagitis

1995 • 30 citations

On demand therapy of reflux oesophagitis — a prospective study of symptoms, patient satisfaction and quality of life

1999 • 25 citations

Esomeprazole

2002 • 21 citations

Audit of reflux oesophagitis at 4 years.

1998 • 8 citations

Long-term therapy of gastro-oesophageal reflux disease: medical or surgical?

2000 • 6 citations

Improving opportunities for effective management of gastro-oesophageal reflux disease

2001 • 5 citations